Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium bromfenac hydrate and pranoprofen eye drops for mild to moderate dry eye
ChiCTR-IPR-15007196Phase 4Recruiting
- Sponsor
- Eye Institute of Xiamen University
- Start
- Oct 2015
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of bromfenac sodium, pranoprofen, fluorometholone and sodium hyaluronate in dry eye syndrome (DED) (4 arms), sponsored by Eye Institute of Xiamen University. Primary endpoints: Tear meniscus height, Tear film break-up time and 1 more. Started Oct 2015; status: recruiting.
02
Drugs
bromfenac sodiumpranoprofenfluorometholonesodium hyaluronate
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR-IPR-15007196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007196.